Moon Surgical, a Paris, France- and San Francisco, CA-based company which specializes in in collaborative robotics, raised additional $55.4M in funding.
The round was co-led by Sofinnova Partners, through its Sofinnova Capital Strategy, and NVIDIA’s venture capital arm, NVentures, with participation from Fred Moll, MD, and Josh Makower, MD. Also joining the round were existing investors GT Healthcare Capital, Cathay Health, Johnson & Johnson Innovation – JJDC, and Sofinnova Partners’ MD Start, as well as Yann Fleureau, Siddarth Satish, Sacha Loiseau, and Richard Leparmentier. As part of the financing, Antoine Papiernik, Chairman of Sofinnova Partners, will be joining Moon Surgical’s Board of Directors, while Mohamed (Sid) Siddeek, Corporate Vice President and Head of NVentures (NVIDIA), and Steve Oesterle, MD, Venture Partner of Cathay Health, will join as Board Observers. With the funding, Moon Surgical also announced the appointment of Fred Moll, MD, as an independent Chair of the Board. Gérard Hascoët will remain a Board Director.
The company intends to use the funds for the continued development and planned commercialization of its Maestro System.
Founded in 2019 by Professor Brice Gayet, Moon Surgical is a new category of Robotic Surgery with its Maestro System, which enhances traditional laparoscopy. Its surgical assistance platform is specifically designed to augment the precision and control of laparoscopic surgery, supporting high-volume surgeons performing procedures such as cholecystectomy and hernia repairs and more complex multi-quadrant procedures.
The financing round follows the company’s other notable accomplishments, which include Maestro’s CE Mark this past April, and 510(k) clearance in December of 2022.
FinSMEs
18/05/2023